163 related articles for article (PubMed ID: 9110301)
41. Immunohistochemical detection of EGFR, p185(erbB-2), Bcl-2 and p53 in breast carcinomas in pre-menopausal and post-menopausal women.
Talley L; Chhieng DC; Bell WC; Grizzle WE; Frost AR
Biotech Histochem; 2008 Feb; 83(1):5-14. PubMed ID: 18568671
[TBL] [Abstract][Full Text] [Related]
42. Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases.
Thompson LD; Becker RC; Przygodzki RM; Adair CF; Heffess CS
Am J Surg Pathol; 1999 Jan; 23(1):1-16. PubMed ID: 9888699
[TBL] [Abstract][Full Text] [Related]
43. PLC-beta2 is highly expressed in breast cancer and is associated with a poor outcome: a study on tissue microarrays.
Bertagnolo V; Benedusi M; Querzoli P; Pedriali M; Magri E; Brugnoli F; Capitani S
Int J Oncol; 2006 Apr; 28(4):863-72. PubMed ID: 16525635
[TBL] [Abstract][Full Text] [Related]
44. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
[TBL] [Abstract][Full Text] [Related]
46. Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer.
Rudolph P; Alm P; Olsson H; Heidebrecht HJ; Fernö M; Baldetorp B; Parwaresch R
Hum Pathol; 2001 Mar; 32(3):311-9. PubMed ID: 11274641
[TBL] [Abstract][Full Text] [Related]
47. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors.
Landberg G; Ostlund H; Nielsen NH; Roos G; Emdin S; Burger AM; Seth A
Oncogene; 2001 Jun; 20(27):3497-505. PubMed ID: 11429696
[TBL] [Abstract][Full Text] [Related]
48. Mucinous cystic tumor of the pancreas: immunohistochemical assessment of "ovarian-type stroma".
Izumo A; Yamaguchi K; Eguchi T; Nishiyama K; Yamamoto H; Yonemasu H; Yao T; Tanaka M; Tsuneyoshi M
Oncol Rep; 2003; 10(3):515-25. PubMed ID: 12684617
[TBL] [Abstract][Full Text] [Related]
49. Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps.
Inceboz US; Nese N; Uyar Y; Ozcakir HT; Kurtul O; Baytur YB; Kandiloglu AR; Caglar H; Fraser IS
Gynecol Obstet Invest; 2006; 61(1):24-8. PubMed ID: 16141722
[TBL] [Abstract][Full Text] [Related]
50. The expression of FOXL2 in pancreatic, hepatobiliary, and renal tumors with ovarian-type stroma.
Westerhoff M; Tretiakova M; Hart J; Gwin K; Liu X; Zhou M; Yeh MM; Antic T
Hum Pathol; 2014 May; 45(5):1010-4. PubMed ID: 24746205
[TBL] [Abstract][Full Text] [Related]
51. Expression of steroid hormone receptors in benign hepatic tumors. An immunocytochemical study.
Masood S; West AB; Barwick KW
Arch Pathol Lab Med; 1992 Dec; 116(12):1355-9. PubMed ID: 1333749
[TBL] [Abstract][Full Text] [Related]
52. Comparative immunohistochemical study of the stroma of serous and mucinous cystic neoplasms: possible histopathogenetic relationship of the 2 entities.
Nguyen BN; Edgecombe A; Gomes M; Soucy G; Marginean CE; Mai KT
Pancreas; 2011 Jan; 40(1):37-41. PubMed ID: 20881895
[TBL] [Abstract][Full Text] [Related]
53. Relation of epidermal growth factor receptor and estrogen receptor-independent pS2 protein to the malignant transformation of mucinous cystic neoplasms of the pancreas.
Kirby RE; Lewandrowski KB; Southern JF; Compton CC; Warshaw AL
Arch Surg; 1995 Jan; 130(1):69-72. PubMed ID: 7802579
[TBL] [Abstract][Full Text] [Related]
54. Pancreatic mucinous cystic neoplasm with sarcomatous stroma: a report of three cases.
Wenig BM; Albores-Saavedra J; Buetow PC; Heffess CS
Am J Surg Pathol; 1997 Jan; 21(1):70-80. PubMed ID: 8990143
[TBL] [Abstract][Full Text] [Related]
55. Cystadenoma and cystadenocarcinoma with mesenchymal stroma of the liver. Immunohistochemical analysis.
Gourley WK; Kumar D; Bouton MS; Fish JC; Nealon W
Arch Pathol Lab Med; 1992 Oct; 116(10):1047-50. PubMed ID: 1384454
[TBL] [Abstract][Full Text] [Related]
56. Study on the estrogen production in parenchymatous cells of epithelial ovarian tumor.
Matsumoto Y
Osaka City Med J; 1992 Jun; 38(1):27-43. PubMed ID: 1528579
[TBL] [Abstract][Full Text] [Related]
57. Giant cell tumor of the pancreas arising in the ovarian-like stroma of a mucinous cystadenocarcinoma.
Bergman S; Medeiros LJ; Radr T; Mangham DC; Lewandrowski KB
Int J Pancreatol; 1995 Aug; 18(1):71-5. PubMed ID: 7594774
[TBL] [Abstract][Full Text] [Related]
58. Hepatobiliary cystadenoma. A study of five cases with reference to histogenesis.
Subramony C; Herrera GA; Turbat-Herrera EA
Arch Pathol Lab Med; 1993 Oct; 117(10):1036-42. PubMed ID: 8215827
[TBL] [Abstract][Full Text] [Related]
59. Antigenic profile of mammary fibroadenoma and cystosarcoma phyllodes. A study using antibodies to estrogen- and progesterone receptors and to a panel of cell surface molecules.
Mechtersheimer G; Krüger KH; Born IA; Möller P
Pathol Res Pract; 1990 Aug; 186(4):427-38. PubMed ID: 2174150
[TBL] [Abstract][Full Text] [Related]
60. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
Forti E; Wolf D; Melia M
Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
